Novartis Plans Up to 130 Job Cuts at Basel Operations
SOURCENews reportView the filing ↗
What we know
Location: Basel, Switzerland.
Department affected: biologics cell banks, analytical testing and technical development laboratories / small-scale biologics production.
A specific layoff date has not been disclosed.
Based on news reporting.
Summary
Novartis announced plans to cut up to 130 jobs at its Basel operations. The company described this as a reduction affecting roles in its Basel site (the article title indicates the locality) and framed the action as a planned workforce reduction rather than completed layoffs. No specific department or exact timing was provided in the article title, and the figure 'up to 130' indicates a maximum planned headcount reduction. The announcement appears to be part of internal restructuring measures, with limited detail on timing, affected functions, or severance terms.
Novartis East Hanover cut 130 jobs affecting its biologics cell banks, analytical testing and technical development laboratories / small-scale biologics production team.
That is roughly 0.1% of the 110,000 people Novartis East Hanover employs.
LayoffTalk has tracked 25 layoff events at Novartis East Hanover since March 2025, including 234 jobs documented in official WARN filings, with 21 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Estimated figure based on news reporting. Not yet confirmed by Novartis East Hanover.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Novartis East Hanover
Recent tracked events at this company.